XFLH Capital signs LOI for business combination with Renogen Biolab - XFLH News | RalliesXFLH Capital signs LOI for business combination with Renogen Biolab
X
XFLH• Non-binding letter of intent signed
- XFLH Capital signed a non-binding letter of intent for a business combination with Renogen Biolab, a Canadian health services provider.
- Renogen provides molecular capabilities including DNA services, vector engineering, and protein expression.
- The parties plan to negotiate definitive agreements as soon as practicable.
- Mutual due diligence will begin, with each side granting access to information to support the review.
•
